1. Home
  2. ROIV vs SLM Comparison

ROIV vs SLM Comparison

Compare ROIV & SLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • SLM
  • Stock Information
  • Founded
  • ROIV 2014
  • SLM 1972
  • Country
  • ROIV United Kingdom
  • SLM United States
  • Employees
  • ROIV N/A
  • SLM N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • SLM Finance: Consumer Services
  • Sector
  • ROIV Health Care
  • SLM Finance
  • Exchange
  • ROIV Nasdaq
  • SLM Nasdaq
  • Market Cap
  • ROIV 7.8B
  • SLM 6.7B
  • IPO Year
  • ROIV N/A
  • SLM N/A
  • Fundamental
  • Price
  • ROIV $11.59
  • SLM $32.92
  • Analyst Decision
  • ROIV Buy
  • SLM Buy
  • Analyst Count
  • ROIV 3
  • SLM 11
  • Target Price
  • ROIV $15.25
  • SLM $33.73
  • AVG Volume (30 Days)
  • ROIV 6.5M
  • SLM 2.2M
  • Earning Date
  • ROIV 08-07-2025
  • SLM 07-24-2025
  • Dividend Yield
  • ROIV N/A
  • SLM 1.57%
  • EPS Growth
  • ROIV N/A
  • SLM N/A
  • EPS
  • ROIV N/A
  • SLM 2.78
  • Revenue
  • ROIV $29,053,000.00
  • SLM $1,449,130,000.00
  • Revenue This Year
  • ROIV $3.28
  • SLM $7.53
  • Revenue Next Year
  • ROIV $156.84
  • SLM $9.62
  • P/E Ratio
  • ROIV N/A
  • SLM $11.50
  • Revenue Growth
  • ROIV N/A
  • SLM N/A
  • 52 Week Low
  • ROIV $8.73
  • SLM $19.39
  • 52 Week High
  • ROIV $13.06
  • SLM $34.97
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 53.30
  • SLM 39.34
  • Support Level
  • ROIV $11.31
  • SLM $32.43
  • Resistance Level
  • ROIV $11.64
  • SLM $33.50
  • Average True Range (ATR)
  • ROIV 0.29
  • SLM 0.92
  • MACD
  • ROIV -0.00
  • SLM -0.21
  • Stochastic Oscillator
  • ROIV 70.23
  • SLM 26.42

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About SLM SLM Corporation

SLM Corp is an education solutions company. It business is to originate and service loans to students and their families to finance the cost of their education. The provide Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.

Share on Social Networks: